Windlas Biotech Ltd
₹1085.65
as on
What are INDmoney investors doing with Windlas Biotech shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+112%
Searches for Windlas Biotech on INDmoney have increased by 112% over the last 30 days.
Investment activity on INDmoney
+239.51%
Investment activity in Windlas Biotech among INDmoney users has increased by 239.51% over the last 30 days.
Average holding period of indmoney investors
46 days
INDmoney investors hold Windlas Biotech shares for an average of 46 days.
Key Events for Windlas Biotech
Windlas Biotech Stock Performance
as on September 16, 2026 at 7:43 pm IST
Day's Low
Day's High
₹1,050.80₹1,099.95
3.21%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
₹697.40₹1,181.9035.76%
Downside
8.87%
Upside
Windlas Biotech share price movements today
- Previous Close
- ₹1,098.15
- Open
- ₹1,085.65
- Volume
- 83.38K
- Upper Circuit
- ₹1,317.75
- Lower Circuit
- ₹878.55
- Day's Low - High
- ₹1,050.80 - ₹1,099.95
- 52 Week Low - High
- ₹697.40 - ₹1,181.90
Windlas Biotech Historical Returns
- 1 Month Return
- + 17.65 %
- 3 Month Return
- + 32.44 %
- 1 Year Return
- + 9.78 %
- 3 Year Return
- + 206.53 %
- 5 Year Return
- + 185.31 %
Windlas Biotech Fundamentals
as on September 16, 2026 at 2:13 pm IST
Market Cap
₹2,266.17 Cr
Return on Equity (ROE)
12.23
PE Ratio (TTM)
35.72
Return on capital employed (ROCE)
15.81
Industry PE ratio
51.81
Beta (LTM)
0.72
P/B Ratio
2.68
Dividend Yield
0.83
PEG Ratio
14.7
Quarterly Earnings Growth YOY
-1.78
EPS (TTM)
31.49
Book Value
275.2
Windlas Biotech Stock Valuation
as on September 16, 2026 at 2:13 pm IST
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (35.72x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (38.93x)
December 6, 2024
Today’s Price to Earnings Ratio: 35.72x
Windlas Biotech Technical Analysis
Track how Windlas Biotech technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.27 | Bullish |
CCI (20) | -415.48 | Bullish |
RSI (14) | 55.23 | Neutral |
Momentum (10) | -0.9 | |
ADI (14) | 27.82 | Bullish |
Ultimate Oscillator (7,14,28) | 65.93 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1086.46 | Bullish |
EMA (20) | 1086.53 | Bullish |
VWMA (20) | 1086.72 | Bullish |
SMA (50) | 1085.95 | Bullish |
EMA (50) | 1086.5 | Bullish |
SMA (200) | 1089.05 | |
EMA (200) | 1087.39 | |
KAMA (200) | 1087.12 | |
DEMA (200) | 1085.7 | Bullish |
Windlas Biotech Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 2,266.17 | 37.06% | 0.53 | 66 | 904 | |
| NA | 29.19 | 47.69% | 0.00 | 1 | NA | |
| BUY | 15,409.97 | 11.25% | 0.50 | 259 | 1,054 | |
| NA | 11.79 | 21.54% | 0.00 | -1 | 21 | |
| HOLD | 14,671.79 | -3.06% | 0.54 | 1,371 | 4,078 |
Windlas Biotech Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Windlas Biotech Ltd Annual Profit & Loss
Figures in Rupees Crores
Windlas Biotech Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Windlas Biotech
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Windlas Biotech
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct Growth | ₹0.01 Cr | ₹0.00 Cr (+5.05%) | 0.04% |
Mutual Funds Exiting Windlas Biotech
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 ICICI Prudential Healthcare Fund Direct Growth | ₹43.87 Cr | ₹16.64 Cr (-27.50%) | 0.57% |
Windlas Biotech Corporate Actions
View detailed summary of the earnings and dividend history of Windlas Biotech.
Windlas Biotech Ltd Earnings Results
Windlas Biotech Ltd’s net profit fell -1.78% since last year same period to ₹15.99Cr in the Q4 2025-2026. On a quarterly growth basis, Windlas Biotech Ltd has generated 6.6% jump in its net profits since last 3-months.
Read More about Earnings ResultsWindlas Biotech Ltd Dividends May,2026
In the quarter ending March 2026, Windlas Biotech Ltd has declared dividend of ₹6.30 per share on 21 May 2026 - translating a dividend yield of 0.56%.
Read More about Dividends
Indices Featuring Windlas Biotech Stock
Check stock indices that include Windlas Biotech.
Insights on Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, WINDLAS stock has moved up by 17.7%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 15.0 Cr → 15.99 Cr (in ₹), with an average increase of 6.2% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.99% to 2.04% in Jun 2026 quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 14 quarters, 121.87 Cr → 242.85 Cr (in ₹), with an average increase of 5.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 63.31% of holdings in Jun 2026 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 41.0%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 6.41% to 5.76% in Jun 2026 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 25.50% to 24.80% in Jun 2026 quarter
About Windlas Biotech Ltd
Revenue: ₹238.50Cr as on March 2026 (Q4 FY26)
Net Profit: ₹15.99Cr as on March 2026 (Q4 FY26)
Listing date: 16 Aug, 2021
Chairperson Name: Vivek Dhariwal
| Organisation | Windlas Biotech Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Vivek Dhariwal |
| E-voting on shares | Click here to vote |
FAQs
What is Windlas Biotech share price today?
Windlas Biotech share price today stands at ₹1085.65 as on . Windlas Biotech share today touched a day high of ₹1099.95 and a low of ₹1050.8.
What is the 52 week high and 52 week low range for Windlas Biotech share?
Windlas Biotech touched a 52 week high of ₹1181.9 and a 52 week low of ₹697.4. Windlas Biotech share price today i.e. is trending at ₹1085.65, which is -8.14% down from its 52 week high and 55.67% up from its 52 week low.
What is Windlas Biotech's market capitalisation today?
Windlas Biotech market capitalisation is ₹2,266.17 Cr as on .
How to buy Windlas Biotech shares?
To buy Windlas Biotech shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for WINDLAS or Windlas Biotech Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Windlas Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Windlas Biotech trading volume today?
Windlas Biotech trading volume is 83.38K as on . This means that 83.38K shares of Windlas Biotech were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Windlas Biotech shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Windlas Biotech have both increased over the past 30 days, and the average INDmoney investor holds the stock for 46 days. This reflects platform activity only and is not investment advice.